The S&P 500 soared more than 32% in 2013, and several big pharma companies, namely Bristol-Myers Squibb (BMY -0.98%), AbbVie (ABBV 0.23%), Roche (RHHBY -1.53%), Johnson & Johnson (JNJ -0.34%), and AstraZeneca (AZN 0.45%) also performed extraordinarily well. The following slideshow reveals why these companies beat out their big pharma peers and what drove their strong performances in 2013.
S&P 500
5,962.08
+0.4%
+$26.14
DJI
42,437.35
+0.3%
+$131.87
NASDAQ
19,375.34
+0.7%
+$132.73
Bitcoin
106,737.00
+2.2%
+2,329.75
AAPL
$202.16
+0.2%
+$0.46
AMZN
$206.70
+0.0%
+$0.05
GOOG
$168.52
-1.1%
-$1.85
META
$665.40
-0.8%
-$5.50
MSFT
$462.07
+0.0%
+$0.10
NVDA
$141.11
+2.7%
+$3.73
TSLA
$350.41
+2.3%
+$7.72
Free Article
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.